about
In vitro infection of human nervous cells by two strains of Toxoplasma gondii: a kinetic analysis of immune mediators and parasite multiplication.Therapy for ocular toxoplasmosis--the future.Vaccines against Toxoplasma gondii: new developments and perspectives.Epidemiology, pathophysiology, and the future of ocular toxoplasmosis.Neuropsychiatric manifestations of latent toxoplasmosis on mothers and their offspring.Central nervous system infections in travelers.Pediatric Uveitis: Experience in Colombia.Decline in Ocular Toxoplasmosis over 40 Years at a Tertiary Referral Practice in the United States.Toxoplasma infection in individuals in central Italy: does a gender-linked risk exist?Risk of Recurrence of Preexisting Ocular Toxoplasmosis during Pregnancy.Infectious uveitis: An enigma.Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.Uveitis in São Paulo, Brazil: 1053 New Patients in 15 Months.Activation of toxoplasma retinochoroiditis during pregnancy and evaluation of ocular findings in newborns.Influence of drug therapy on the risk of recurrence of ocular toxoplasmosis.Immunological interaction between Giardia cyst extract and experimental toxoplasmosis.Assessment of ocular toxoplasmosis patients reported at a tertiary center in the northeast of Iran.DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice.Ocular Toxoplasmosis in Tropical Areas: Analysis and Outcome of 190 Patients from a Multicenter Collaborative Study.Patterns of ocular toxoplasmosis presenting at a tertiary eye care center in Korean patients.Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis.
P2860
Q33700082-DEE57F64-4FC4-49BE-A66B-CE046E534EB3Q38101597-CF87682C-3B81-4F42-BF04-CD2023520D0FQ38149266-C9459C98-4D98-4069-B96F-97D15DF3E295Q38153080-A5AF57C1-A464-4E71-9A23-9FC6A0C1047CQ38155237-FA236F61-8C0E-41D2-849B-82F9C7D89347Q38159976-2CCA32E6-0B25-427F-B766-322720CEED1DQ38837297-97C6F902-D2A2-4C5C-BA7A-A6D08B702210Q39021968-6DE71807-56F8-4544-93AD-F3B21A68051AQ39109355-9C8FCE68-8558-49E7-93BB-F95C3064C633Q39189944-FD06F2B6-AB5D-4331-BE96-374ADBADEA75Q39331472-1E37AB70-B421-408F-872B-1A662447FC0DQ39378103-AC3C4212-88BC-411F-B0F6-7F191CD8B04AQ39969325-0050B287-D36D-4C95-8E68-F7F08FF0F8FCQ40592848-EA9AE435-1CA1-49FD-A11D-842CE8D6B99DQ40749223-9DBF259A-A42B-4E82-8B6E-84DCEEF40331Q46208643-24E875A8-3D7A-4324-9467-40519826460CQ47553070-EE713FD0-785E-4718-986C-3CDD26BEAED5Q48292361-5E02D602-E108-42EC-AB1E-B8B05FA80B79Q48576014-3949E952-707A-4035-A575-85CC3D494449Q53074436-BAA15000-FE1E-4E12-A472-BB09B98D05A6Q54216999-8D0E8570-3488-47E0-9240-14729F1F8D5C
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Epidemiology of ocular toxoplasmosis.
@ast
Epidemiology of ocular toxoplasmosis.
@en
Epidemiology of ocular toxoplasmosis.
@nl
type
label
Epidemiology of ocular toxoplasmosis.
@ast
Epidemiology of ocular toxoplasmosis.
@en
Epidemiology of ocular toxoplasmosis.
@nl
prefLabel
Epidemiology of ocular toxoplasmosis.
@ast
Epidemiology of ocular toxoplasmosis.
@en
Epidemiology of ocular toxoplasmosis.
@nl
P2860
P1476
Epidemiology of ocular toxoplasmosis.
@en
P2093
Miles Stanford
P2860
P356
10.3109/09273948.2012.661115
P577
2012-04-01T00:00:00Z